Endocrinological effects of intrathecal morphine

Area of Science:

• Anesthesiology
• Endocrinology
• Pharmacology

Background:

• Coronary artery surgery requires effective pain management.
• Metabolic responses to anesthesia and surgery can impact patient outcomes.
• Intrathecal drug administration offers targeted delivery with potential systemic effects.

Purpose of the Study:

• To evaluate the metabolic effects of intrathecal morphine in patients undergoing coronary artery surgery.
• To assess the impact of intrathecal morphine on catecholamine, cortisol, and glucose levels.
• To determine the analgesic efficacy of intrathecal morphine in the post-operative period.

Main Methods:

• A comparative study involving two groups of 10 patients each.
• One group received intrathecal morphine (4 mg in 6 ml saline) before surgery.
• Measurements of catecholamines, cortisol, and glucose were taken during and for 24 hours post-surgery.

Main Results:

• The intrathecal morphine group required less post-operative papaveretum, indicating effective analgesia.
• Cortisol secretion was significantly suppressed in the intrathecal morphine group from the end of surgery to 5 hours post-operatively.
• No significant differences in catecholamine or glucose levels were reported between groups.

Conclusions:

• Intrathecal morphine is effective for post-operative analgesia in coronary artery surgery.
• Intrathecal morphine administration leads to suppressed cortisol secretion in the early post-operative phase.
• Further research is warranted to fully elucidate the metabolic consequences of intrathecal morphine in cardiac surgical patients.